IDEX
IDEX's revenue rose 5.8% to $3.5 billion in fiscal 2025. Its operating margin was 20.2%, down from 20.7% a year earlier. Free cash flow was $617 million, up 2.3%. It paid out $460 million in dividends and buybacks, 75% of free cash flow. The diluted share count fell 0.8%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 6.9% a year and net income 6.6% a year, as buybacks cut the share count by 2%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value IDEX yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from IDEX's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from IDEX's fiscal 2025 free cash flow of $617M, net cash of −$1.2B at December 31, 2025 and 75 million diluted shares, from its filings. The scenarios are fitted to IDEX: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 2.8% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Industrial Machinery & Supplies & Components); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $231.06
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from IDEX's earnings per share of $6.95 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.7×, the middle of IDEX's own P/E today, its peers' median and its sector's median (the Industrials median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $231.06
- Value at this multiple, against the last close
- —
- IDEX's P/E at the last close
- 33.2×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| ITTITT | $190.79 | $5.11 | 37.3× |
| IDEXIEX | $231.06 | $6.95 | 33.2× |
| Carpenter TechnologyCRS | $289.48 | $11.34 | 25.5× |
| DonaldsonDCI | $85.51 | $3.85 | 22.2× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 855 | 430 | 534 | 621 | 580 |
| Debt incl. finance leases | 1,190 | 1,478 | 1,333 | 1,971 | 1,830 |
| Net debt (negative means net cash) | 335 | 1,048 | 799 | 1,350 | 1,250 |
| Net debt to EBITDA | 0.5x | 1.2x | 0.9x | 1.6x | 1.4x |
| Debt to equity | 0.4x | 0.5x | 0.4x | 0.5x | 0.5x |
| Interest coverage | 15.5x | 18.5x | 14.2x | 14.3x | 9.7x |
| Current ratio | 3.5x | 2.6x | 2.9x | 2.5x | 2.9x |
| Quick ratio | 2.7x | 1.7x | 2.0x | 1.9x | 2.0x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $101,646 of IDEX shares on the open market, and 2 insiders sold $3.4 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Lisa M AndersonSVP, GC, CAO & Corp Sec | Sold | 385 | $238.59 | $91,857 | Form 4 |
| May 11, 2026 | Eric D AshlemanCEO and President, Director | Sold | 15,385 | $215.22 | $3.3 million | Form 4 |
| Nov 5, 2025 | Carl R ChristensonDirector | Bought | 600 | $169.41 | $101,646 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 6 of 9 | 5 of 9 | 7 of 9 |
| Accruals ratio | −2.1% | −2.6% | −2.9% |
Compare
Put IDEX side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| IDEX | FY25 | 5.8% | 20.2% | 17.8% | 10.2% | 1.4x | 7 | |
| Middleby | FY25 | 1.6% | 18.0% | 17.5% | 8.7% | 2.9x | 4 | Compare |
| Carpenter Technology | FY26 | 8.6% | 22.5% | 11.6% | 23.7% | 0.3x | 9 | Compare |
| Donaldson | FY26 | 5.3% | 15.4% | 11.0% | 19.4% | 1.5x | 7 | Compare |
| ITT | FY25 | 8.5% | 17.4% | 13.9% | 16.8% | −1.2x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 2,113 | 2,287 | 2,484 | 2,495 | 2,352 | 2,765 | 3,182 | 3,274 | 3,269 | 3,458 |
| Revenue growth | 4.6% | 8.2% | 8.6% | 0.4% | −5.7% | 17.6% | 15.1% | 2.9% | −0.2% | 5.8% |
| Gross profit | 931 | 1,027 | 1,118 | 1,125 | 1,027 | 1,224 | 1,427 | 1,447 | 1,445 | 1,539 |
| Research and development | 39 | 42 | 48 | 56 | 48 | 50 | 61 | 68 | 67 | 70 |
| Operating income | 412 | 503 | 569 | 579 | 521 | 637 | 751 | 732 | 677 | 699 |
| Net income | 271 | 337 | 411 | 426 | 378 | 449 | 587 | 596 | 505 | 483 |
| Diluted EPS (US$) | 3.53 | 4.36 | 5.29 | 5.56 | 4.94 | 5.88 | 7.71 | 7.85 | 6.64 | 6.41 |
| Diluted shares (millions) | 77 | 77 | 78 | 76 | 76 | 76 | 76 | 76 | 76 | 75 |
| Cash flow | ||||||||||
| Cash from operations | 400 | 433 | 479 | 528 | 569 | 565 | 557 | 717 | 668 | 680 |
| Capital expenditure | 38 | 44 | 56 | 51 | 52 | 73 | 68 | 90 | 65 | 64 |
| Free cash flow | 362 | 389 | 423 | 477 | 518 | 493 | 489 | 627 | 603 | 617 |
| Dividends paid | 103 | 111 | 128 | 147 | 152 | 161 | 177 | 191 | 205 | 213 |
| Share buybacks | 57 | 29 | 174 | 55 | 110 | 0 | 148 | 24 | 0 | 248 |
| Acquisitions | 510 | 38 | 20 | 87 | 123 | 577 | 946 | 312 | 984 | 76 |
| Stock-based compensation | 20 | 24 | 25 | 22 | 15 | 20 | 22 | 22 | 26 | 27 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 236 | 376 | 466 | 633 | 1,026 | 855 | 430 | 534 | 621 | 580 |
| Debt incl. finance leases | 1,022 | 862 | 852 | 850 | 1,045 | 1,190 | 1,478 | 1,333 | 1,971 | 1,830 |
| Total assets | 3,155 | 3,400 | 3,474 | 3,814 | 4,414 | 4,917 | 5,512 | 5,865 | 6,745 | 6,927 |
| Total liabilities | 1,611 | 1,513 | 1,479 | 1,551 | 1,874 | 2,114 | 2,472 | 2,324 | 2,951 | 2,901 |
| Shareholders' equity | 1,544 | 1,886 | 1,995 | 2,263 | 2,540 | 2,803 | 3,039 | 3,541 | 3,795 | 4,028 |
| Margins and ratios | ||||||||||
| Gross margin | 44.0% | 44.9% | 45.0% | 45.1% | 43.7% | 44.3% | 44.8% | 44.2% | 44.2% | 44.5% |
| Operating margin | 19.5% | 22.0% | 22.9% | 23.2% | 22.1% | 23.0% | 23.6% | 22.4% | 20.7% | 20.2% |
| Net margin | 12.8% | 14.7% | 16.5% | 17.1% | 16.1% | 16.2% | 18.4% | 18.2% | 15.4% | 14.0% |
| Free cash flow margin | 17.1% | 17.0% | 17.0% | 19.1% | 22.0% | 17.8% | 15.4% | 19.1% | 18.4% | 17.8% |
| Return on capital | 14.1% | 15.8% | 18.6% | 19.0% | 16.6% | 17.3% | 16.3% | 13.6% | 11.3% | 10.2% |
| Return on equity | 18.1% | 19.7% | 21.2% | 20.0% | 15.7% | 16.8% | 20.1% | 18.1% | 13.8% | 12.3% |
| Return on assets | 9.1% | 10.3% | 11.9% | 11.7% | 9.2% | 9.6% | 11.3% | 10.5% | 8.0% | 7.1% |
| Net debt to EBITDA | 1.6x | 0.8x | 0.6x | 0.3x | 0.0x | 0.5x | 1.2x | 0.9x | 1.6x | 1.4x |